CROLIUS CLAYTON (Chief Financial Officer) purchased 86.70K shares of DNA X, INC. on the open market
Open‑market purchase worth $59.2K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/18/2023ACC: 0001493152-23-032976
Officer· Chief Financial Officer
Since Jul 2022
+86.70K
Net shares
Net buyer
$59.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
86.70K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+86.70K
Price / share
$0.68
Trade value
$59.22K
% of position
New position
9/15/2023
0.00→86.70K
Total
Net shares
+86.70K
Net value
$59.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2023 | P · Purchase | +86.70K | $0.68 | $59.22K | New position | 0.00 | 86.70K |
| Total | +86.70K | $59.22K | ||||||
Derivative Transactions0
No derivative transactions reported